JPRN-UMIN000003936招募中4 期
Therapeutic effects of direct renin inhibitor aliskiren on ambulatory blood pressure profile in essential hypertensives - Therapeutic effects of direct renin inhibitor aliskiren on ambulatory blood pressure profile in essential hypertensives
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine0 个研究点目标入组 40 人开始时间: 2010年7月21日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Office systolic blood pressure >= 180 mmHg, or office diastolic blood pressure >= 110 mmHg. 2. Heart disease, cerebrovascular disease, or ckronic kidney disease with urinary protein excretion >= 300 mg/g-cr or estimated GFR < 60 ml/min/1.73 m2. 3. Cyclosporin treatment. 4. History of hypersensitivity of aliskiren. 5. Pregnant women or women suspect of being pregnant. 6. Arrhythmia. 7. Secondary hypertension. 8. Patients ineligible for the study determined by doctors
研究者
相似试验
已完成
4 期
Therapeutic effects of direct renin inhibitor aliskiren added to AT1 receptor blocker in hypertensive patients with chronic kidney disease.Hypertension Chronic kidney diseaseJPRN-UMIN000002546Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine100
已完成
不适用
Therapeutic effects of direct renin inhibitor in end stage kidney disease patients with maintenance hemodialysisHypertension,End stage kidney diseaseJPRN-UMIN000003551Yamamoto general hospital40
已完成
不适用
The efficacy and safety of direct renin inhibitor aliskiren on the blood glucose control of DPP-IV inhibitortype 2 diabetes mellitus hypertensionJPRN-UMIN000004925Department of Internal Medicine, School of Medicine, Keio University70
进行中（未招募）
不适用
Effect of direct renin-inhibition aliskiren on renal haemodynamic and metabolic parameters in patients with prediabetes - AMARYLISEUCTR2008-008287-28-DEniversity Hospital Erlangen20
已完成
不适用
A prospective comparison of direct renin inhibitor aliskiren and AT1 receptor blocker in hypertensive patients with chronic kidney disease(CKD).Hypertension Chronic kidney diseaseJPRN-UMIN000008615Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine100